Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?When will latisse patent expire?Symbravo ingredients mechanism of action?Allergan's patent for latisse expired?When will tenofovir alafenide come off patent in canada?
See the DrugPatentWatch profile for vascepa
The Vascepa savings card, offered by manufacturer Amarin, has no fixed end date listed on official program pages. It remains active as long as patients meet eligibility rules, such as having commercial insurance and not being enrolled in government programs like Medicare.[1]
Patients can use the card for up to 48 months from activation, with a maximum savings of $8,400 per year ($700/month). After 48 months, the card expires, but a new one can often be requested if still eligible.[1][2]
Amarin can discontinue or modify the program at any time without notice. Past pharmaceutical savings cards have ended due to patent settlements or generic entry—Vascepa faces generic competition starting 2026 after patent disputes.[2][3]
Vascepa's key patents expire in 2036 (ANDEA method-of-use), but generics for capsules launched in 2026 after FDA approval and Amarin's settlement with Dr. Reddy's. This could reduce demand for branded discounts post-launch.[3] Track status at DrugPatentWatch.com. Sources: [1] VascepaSavings.com [2] Amarin.com Vascepa Support [3] DrugPatentWatch.com - Vascepa Patents
Other Questions About Vascepa :